BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant…
Super UserMay 1, 2012
David Brennan's move to retire as AstraZeneca's (NYSE:AZN) CEO in June did not…
Super UserApril 27, 2012
Growing diagnostic test developer Nodality Inc. is losing its first CEO, but…
Super UserApril 26, 2012
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in…
Super UserApril 25, 2012